Correction to: Diabetes Ther (2020) 11:1017–1027 10.1007/s13300-020-00781-6
In the original publication, the timing of baseline CGM assessment was incorrectly stated in the text in two instances; it is correct in Fig. 1.
In the “Data Collection” section, the sentence “Baseline and investigational CGM values are assessed during weeks 0–3 and 9–12, respectively…” should state “Baseline and investigational CGM values are assessed during weeks −3 to 0 and 9 to 12, respectively…”
In the “Statistical Analysis” section, the sentence “The percentage of time in the glucose range of ≥ 70 to ≤ 180 mg/dL (≥ 3.9 to ≤ 10 mmol/L) at week 12 will be assessed in both arms using 20 days of blinded CGM data during weeks 0–3 and 9–12” should state “The percent time in the glucose range of ≥ 70 to ≤ 180 mg/dL (≥ 3.9 to ≤ 10 mmol/L) at week 12 will be assessed using data generated during the randomised period.”
Open Access
This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.